Literature DB >> 1955096

Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.

J L Leahy1, G C Weir.   

Abstract

Glucose-induced insulin secretion is lost in the face of chronic hyperglycaemia. The same defect is present when normal rats are made hyperglycaemic by 48-h glucose infusions. Insulin secretory responses were mapped out during the post-infusion period in order to determine how long it takes for normal Beta-cell function to recover, and to identify factors which influence the rate of recovery. Male Sprague Dawley rats weighing 200-250 g were infused with 50% glucose or 77 mmol/l NaCl for 48 h. The glucose-infused rats were mildly hypoglycaemic for 14 h after the infusion ceased. Glucose-induced insulin secretion, absent at the end of the glucose infusion, was normal 6 h post-infusion. Such rapid recovery was not because of the short duration of hyperglycaemia; mild hypoglycaemia from a 5-h insulin infusion in 90% pancreatectomized rats resulted in a four-fold rise in glucose-induced insulin secretion. Under in vitro conditions, extreme glucose deprivation caused by perfusing the pancreas of glucose-infused rats with buffer devoid of glucose restored glucose-induced insulin secretion in just 37 min. Therefore, the suppression of glucose-induced insulin release by chronic hyperglycaemia is a dynamic situation that requires ongoing hyperglycaemia to prevent the reappearance of glucose responsiveness. This study shows recovery of glucose-induced insulin secretion after just 6 h of mild hypoglycaemia in vivo and even faster recovery with more severe glucose deprivation in vitro. Our results suggest that there is an inverse relationship between the rate of return of Beta-cell glucose responsiveness and the ambient glucose concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955096     DOI: 10.1007/bf00400993

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Evolution of insulin secretory response to glucose by perifused islets from lean (FA/FA) rats chronically infused with glucose.

Authors:  F J Bedoya; B Jeanrenaud
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

2.  Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats.

Authors:  K I Timmers; A M Powell; N R Voyles; D Solomon; S D Wilkins; S Bhathena; L Recant
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

3.  Presence and mobilization of glycogen in mammalian pancreatic beta cells.

Authors:  B Hellman; L A Idahl
Journal:  Endocrinology       Date:  1969-01       Impact factor: 4.736

4.  Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance.

Authors:  G C Weir
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

5.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia.

Authors:  P Vague; J P Moulin
Journal:  Metabolism       Date:  1982-02       Impact factor: 8.694

6.  Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

Authors:  L Rossetti; G I Shulman; W Zawalich; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

7.  Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.

Authors:  V Grill; M Rundfeldt
Journal:  Diabetes       Date:  1986-01       Impact factor: 9.461

8.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

Authors:  J L Leahy; H E Cooper; D A Deal; G C Weir
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  8 in total

1.  Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs.

Authors:  M O Larsen; C F Gotfredsen; M Wilken; R D Carr; N Pørksen; B Rolin
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

2.  Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.

Authors:  Rachel A Jamison; Romana Stark; Jianying Dong; Shin Yonemitsu; Dongyan Zhang; Gerald I Shulman; Richard G Kibbey
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

3.  Chronic Glucose Exposure Systematically Shifts the Oscillatory Threshold of Mouse Islets: Experimental Evidence for an Early Intrinsic Mechanism of Compensation for Hyperglycemia.

Authors:  Eric Glynn; Benjamin Thompson; Suryakiran Vadrevu; Shusheng Lu; Robert T Kennedy; Joon Ha; Arthur Sherman; Leslie S Satin
Journal:  Endocrinology       Date:  2015-12-23       Impact factor: 4.736

4.  Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.

Authors:  M C Cam; R A Pederson; R W Brownsey; J H McNeill
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

5.  Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.

Authors:  J Seufert; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

6.  Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).

Authors:  Y A Hosokawa; H Hosokawa; C Chen; J L Leahy
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men.

Authors:  N Leung; T Sakaue; A Carpentier; K Uffelman; A Giacca; G F Lewis
Journal:  Diabetologia       Date:  2004-01-08       Impact factor: 10.122

8.  Clinical Characteristics Associated with the Development of Diabetic Ketoacidosis in Patients with Type 2 Diabetes.

Authors:  Seizaburo Masuda; Kazuki Ota; Rei Okazaki; Ryoko Ishii; Keiho Cho; Yuki Hiramatsu; Yuko Adachi; Sayo Koseki; Eri Ueda; Isao Minami; Tetsuya Yamada; Takayuki Watanabe
Journal:  Intern Med       Date:  2022-04-15       Impact factor: 1.282

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.